CION Investment Corp. Q1 2021 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2021. CION Investment Corp. is an externally managed, non-diversified closed-end management investment company regulated as a Business Development Company (BDC) under the Investment Company Act of 1940. The Company's investment objective is to generate current income and, to a lesser extent, capital appreciation, primarily through senior secured debt investments in U.S. middle-market companies.
Key Financial Metrics
| Metric | Q1 2021 | Q1 2020 | Dec 31, 2020 |
|---|---|---|---|
| Net Asset Value (NAV) per Share | $8.06 | $7.29 | $7.75 |
| Total Investments (Fair Value) | $1,621,641 | $1,569,371 | $1,569,371 |
| Net Investment Income | $17,599 | $21,661 | $78,728 (FY) |
| Net Increase in Net Assets from Operations | $49,714 | $(105,912) | $(11,022) (FY) |
| Net Realized Gains (Losses) | $(4,128) | $(4,196) | $(69,872) (FY) |
| Net Unrealized Appreciation (Depreciation) | $36,243 | $(123,377) | $(19,878) (FY) |
| Total Financing Arrangements (Outstanding) | $725,000 | $725,000 | $725,000 |
| Cash and Cash Equivalents | $1,641 | $3,727 | $19,914 |
| Asset Coverage Ratio | 2.26x | 2.02x | 2.21x |
Material Changes vs. Prior Period
- Operational Performance: The Company reported a net increase in net assets of $49.7 million for Q1 2021, a significant improvement from the $105.9 million decrease in Q1 2020. This turnaround was driven primarily by a $36.2 million net unrealized appreciation on investments, contrasting with a $123.4 million unrealized depreciation in the prior year period.
- Investment Income: Total investment income decreased to $36.3 million from $45.7 million in Q1 2020. This decline was attributed to a smaller average investment portfolio size and lower LIBOR rates.
- Operating Expenses: Total operating expenses decreased to $18.7 million from $24.1 million. Notably, the subordinated incentive fee on income was $0 in Q1 2021 compared to $3.3 million in Q1 2020, due to lower net investment income. Interest expense also declined to $7.5 million from $10.5 million.
- Portfolio Composition: The portfolio consists of 122 companies. Senior secured first lien debt represents 81.8% of the portfolio by fair value. Healthcare & Pharmaceuticals (18.7%) and Business Services (13.8%) are the largest industry allocations.
Guidance, Outlook, and Risks
- Recent Financing: In April 2021 (subsequent to the period end), the Company entered into a $30 million unsecured term loan facility with More Provident Funds Ltd. at 5.20% interest, maturing in September 2024.
- Debt Structure: As of March 31, 2021, the Company had $500 million outstanding under the JPM Credit Facility, $125 million in 2026 Notes, and $100 million under the UBS Facility. The Company maintains an asset coverage ratio of 2.26x, well above the 200% minimum requirement.
- Unfunded Commitments: The Company had $75.7 million in unfunded commitments as of March 31, 2021, which increased to $80.0 million as of May 10, 2021. These commitments are funded through cash on hand, short-term investments, and borrowings.
- Risks: Management highlights the ongoing impact of the COVID-19 pandemic on portfolio companies and global economic conditions. The Company notes that while restrictions have loosened, economic distress may persist, potentially leading to investment impairments or restructuring. Additionally, the Company is subject to interest rate risk, with 85.1% of investments bearing floating rates.
- Distributions: The Company declared monthly cash distributions of $0.04413 per share for April and May 2021. Distributions are funded primarily from net investment income.
Key Facts for Investor Verification
- NAV Growth: Verify the sustainability of the $0.31 per share NAV increase ($7.75 to $8.06) driven largely by unrealized gains rather than cash flow.
- Debt Covenants: Confirm continued compliance with the 200% asset coverage ratio and other covenants in the JPM Credit Facility and 2026 Notes, especially given the new $30 million unsecured term loan.
- Unfunded Commitments: Assess liquidity adequacy to fund the $80 million in unfunded commitments without diluting shareholders or breaching leverage limits.
- Portfolio Quality: Review the credit rating distribution; 18.8% of the portfolio is rated "3" (increased risk but full return expected), while 0.6% is rated "4" or "5" (significant risk of loss).
- Expense Support: Note that the Company did not receive expense support from its adviser (CIM) in Q1 2021, but the conditional reimbursement agreement remains in effect through December 2021.